Pattarachai Kiratisin

Pattarachai Kiratisin

Auto-generated profile, based on publicly available information

Pattarachai Kiratisin

Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2014 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
TNThidarat Netikul
Thidarat Netikul
HSHanna E. Sidjabat
Hanna E. Sidjabat
DPDavid L Paterson
David L Paterson
WKWitchuda Kamolvit
Witchuda Kamolvit
WTWoraphot Tantisiriwat
Woraphot Tantisiriwat
PKPattarachai Kiratisin
Pattarachai Kiratisin

25 September 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TNThidarat Netikul
Thidarat Netikul
PKPattarachai Kiratisin
Pattarachai Kiratisin
Carbapenem-resistant Enterobacteriaceae (CRE) has increasingly spread worldwide in the past decade. The prevalence and characteristics of CRE in Thailand are unknown. In this study, we conducted a 2-year surveillance of CRE among 12,741 clinical isolates of Enterobacteriaceae at the largest university hospital in Thailand with molecular characterization of beta-lactamase (bla) genes, including carbapenemase genes. The CRE prevalence was 1.4%. blaKPC-13 and blaIMP-14a were the only carbapenemase genes detected among these CRE isolates. blaKPC-13 gene was found in a single isolate of Escherichia coli, Enterobacter cloacae and Citrobacter freundii, and blaIMP-14a was found in four isolates of Klebsiella pneumoniae. Carbapenem-resistant K. pneumoniae (CRKP) isolates were resistant to multiple carbapenems at a higher ratio than other CRE species, and thus were further characterized for resistance phenotypes, bla genotypes and molecular epidemiology. Most CRKP isolates harboured multiple bla genes, especially those related to extended-spectrum beta-lactamases. Seven CRKP isolates were resistant to all tested carbapenems, and showed decreased ompK35 and/or ompK36 porin gene expression. Molecular typing of CRKP based on pulsed-field gel electrophoresis (PFGE) demonstrated several unrelated clones. Multilocus sequence typing (MLST) was partially concordant with PFGE results and revealed that ST340, a member of drug-resistant K. pneumoniae clonal complex 258, was the most predominant clone, followed by ST48, ST11 and ST273. The novel ST1645 was identified from this study. ST340 has neither been shown to be predominated among CRKP from other studies, nor been reported in Thailand. Therefore, it emphases a critical concern to monitor and control the spread of CRKP.

1 April 2019 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
PPPipat Piewngam
Pipat Piewngam
MQMariam Quiñones
Mariam Quiñones
WTWitoon Thirakittiwatthana
Witoon Thirakittiwatthana
TYThitiya Yungyuen
Thitiya Yungyuen
MOMichael Otto
Michael Otto
PKPattarachai Kiratisin
Pattarachai Kiratisin

17 August 2021 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
TYThitiya Yungyuen
Thitiya Yungyuen
TCTanittha Chatsuwan
Tanittha Chatsuwan
RPRongpong Plongla
Rongpong Plongla
SKSakawrat Kanthawong
Sakawrat Kanthawong
UYUmaporn Yordpratum
Umaporn Yordpratum
PKPattarachai Kiratisin
Pattarachai Kiratisin
A large-scale surveillance is an important measure to monitor the regional spread of antimicrobial resistance. We prospectively studied the prevalence and molecular characteristics of clinically important Gram-negative bacilli, including Escherichia coli , Klebsiella pneumoniae , Acinetobacter baumannii complex (ABC), and Pseudomonas aeruginosa , from blood, respiratory tract, urine, and sterile sites at 47 hospitals across Thailand.

1 December 2021 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Open access
PKPattarachai Kiratisin
Pattarachai Kiratisin
KKKrystyna Kazmierczak
Krystyna Kazmierczak
GSGregory G. Stone
Gregory G. Stone
This study reports the antimicrobial activity of ceftazidime/avibactam (CZA) and comparators against carbapenemase-producing Enterobacterales (N = 1992) and carbapenemase-producing Pseudomonas aeruginosa (N = 784) collected in Africa/Middle East, Asia/South Pacific, Europe and Latin America (2016-2018). Minimum inhibitory concentrations (MICs) and susceptibility were determined using broth microdilution methodology and EUCAST breakpoints. Carbapenemase-encoding genes were detected using multiplex PCR. No isolates of carbapenemase-producing, metallo-β-lactamase (MBL)-negative Enterobacterales from Africa/Middle East or Latin America were resistant to CZA; resistance rates in Europe and Asia/South Pacific were ≤4.5%. Colistin had the lowest resistance rate among MBL-positive isolates (6.0-11.4%). Enterobacterales isolates collected in Latin America predominantly carried a KPC carbapenemase (77.6%), whereas in Africa/Middle East OXA-48-like carbapenemases were most frequently detected (55.9%), and in Asia/South Pacific most isolates carried NDM carbapenemases (56.2%). Among all Enterobacterales carrying KPC carbapenemases, the lowest rate of resistance was to CZA (1.5%), and among isolates carrying NDM carbapenemases it was to colistin (10.8%). Among carbapenemase-producing, MBL-negative P. aeruginosa, resistance rates to CZA were 8.6% for isolates collected in Europe and 53.2% in Latin America. Isolates in each region most frequently carried VIM carbapenemases, ranging from 41.7% of isolates in Asia/South Pacific to 86.2% in Africa/Middle East. No P. aeruginosa carrying KPC or NDM carbapenemases and 1.0% of isolates carrying GES carbapenemases were resistant to colistin. Given the limited therapeutic options to treat infections caused by carbapenemase-positive Enterobacterales and P. aeruginosa, continued surveillance of CZA activity as well as agents such as colistin is crucial.